TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Scientists say that aiming chimeric antigen receptor (CAR) T cells at both B7-H3 and B cell maturation antigen (BCMA), which is effective alone but still vulnerable to therapeutic resistance,...

Observations from a mouse model of graft-versus-host disease (GVHD) shed light on the role Enterococcus faecalis plays in this complication of allogeneic hematopoietic cell transplantation...

Researchers are encouraged by the early performance of multi-antigen T-cells in the setting of pancreatic ductal adenocarcinoma (PDAC), a cancer that has largely resisted immunotherapy.

Researchers agree on the robust potential of belumosudil as a treatment for chronic graft-versus-host disease (cGVHD), which can develop following allogeneic hematopoietic stem cell...

Chimeric antigen receptor (CAR) T-cell treatment has had limited success against pancreatic ductal adenocarcinoma (PDAC), but there is hope that incorporating ibrutinib or PD-1 blockade might...

Scientists developed a conditioning protocol that, followed by allogeneic bone marrow transplantation and islet transplantation, produces a favorable mix of host and donor hematopoietic stem cells...